Biotronik Neuro acquires Soin Neuroscience SCS patent portfolio

• Biotronik Neuro acquired a portfolio of spinal cord stimulation patents from Soin Neuroscience.¹
• Soin Neuroscience is an Ohio-based medical device company.¹
• The deal is aimed at building a next-generation spinal cord stimulation program for pain.¹
• The acquisition expands Biotronik Neuro’s neuromodulation assets in spinal cord stimulation.¹
• FierceBiotech reported the Biotronik–Soin patent portfolio transaction as a next-gen pain project.^{1 1}

Footnotes

1. https://www.fiercebiotech.com/medtech/biotronik-neuro-snaps-spinal-cord-stimulation-portfolio-soin-neuroscience-next-gen-pain ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶